Table 2.

Kinetic Parameters of FPGS With MTX as Substrate and Accumulation of MTX Polyglutamates in ALL and AML Patients

DiagnosisKmVmaxLong Chain MTX PolyglutamatesLong Chain MTX Polyglutamates as % of Total Polyglutamates
(μmol/L)(pmol/mg/h)(pmol/107 cells)
ALL 48 14,450 9  90 
ALL 23 1,065 12.7 66 
ALL 47 1,832 16.3 86 
Lymphoid BC/CML 45 6,600 30.8 88 
AML 75 1,490 3.36 24 
AML 83 2,030 ND ND 
AML 100 1,000 ND ND 
DiagnosisKmVmaxLong Chain MTX PolyglutamatesLong Chain MTX Polyglutamates as % of Total Polyglutamates
(μmol/L)(pmol/mg/h)(pmol/107 cells)
ALL 48 14,450 9  90 
ALL 23 1,065 12.7 66 
ALL 47 1,832 16.3 86 
Lymphoid BC/CML 45 6,600 30.8 88 
AML 75 1,490 3.36 24 
AML 83 2,030 ND ND 
AML 100 1,000 ND ND 

Cells extracts were prepared as described in Materials and Methods. MTX at different concentrations was used to measure enzyme activity and to determine Km and Vmax values. Polyglutamates formation was measured after 24-hour exposure to radiolabeled MTX as described in Materials and Methods.

Abbreviation: ND, not done (insufficient sample).

or Create an Account

Close Modal
Close Modal